Medical policy
Short-Acting Beta2-Agonist Inhalers
Cigna medical policy IP0040 · May 15, 2023
Key facts
| Policy title | Short-Acting Beta2-Agonist Inhalers |
|---|---|
| Insurer | Cigna |
| Policy number | IP0040 |
| Policy date | May 15, 2023 |
| Current policy | Yes |
| Insurer page | static.cigna.com |
At a glance
- None 510(k)s referenced
- None PMAs referenced
- None De Novos referenced
- None Clinical trials referenced
- 1–9 Articles referenced
- None UDI devices referenced
- None NDC products referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Insurer medical policies
Insurer clinical and medical policies state when a payer covers a device, drug or procedure. Orca1 links each policy to the FDA submissions, trials and articles it cites. Policy text is not reproduced here.
Source: Health insurer clinical and medical policies (insurer as listed); cross-links by Orca1